6-4130464-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_206836.3(ECI2):āc.409A>Gā(p.Thr137Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000128 in 1,614,250 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_206836.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ECI2 | NM_206836.3 | c.409A>G | p.Thr137Ala | missense_variant | 4/10 | ENST00000380118.8 | NP_996667.2 | |
TEX56P | NR_104463.3 | n.2785-21T>C | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ECI2 | ENST00000380118.8 | c.409A>G | p.Thr137Ala | missense_variant | 4/10 | 1 | NM_206836.3 | ENSP00000369461 | P1 | |
TEX56P | ENST00000643110.1 | n.1368-21T>C | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 152242Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000135 AC: 34AN: 251426Hom.: 0 AF XY: 0.000162 AC XY: 22AN XY: 135878
GnomAD4 exome AF: 0.000129 AC: 188AN: 1461890Hom.: 0 Cov.: 31 AF XY: 0.000122 AC XY: 89AN XY: 727248
GnomAD4 genome AF: 0.000125 AC: 19AN: 152360Hom.: 0 Cov.: 32 AF XY: 0.0000940 AC XY: 7AN XY: 74500
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 20, 2023 | The c.409A>G (p.T137A) alteration is located in exon 4 (coding exon 4) of the ECI2 gene. This alteration results from a A to G substitution at nucleotide position 409, causing the threonine (T) at amino acid position 137 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at